Zobrazeno 1 - 10
of 1 879
pro vyhledávání: '"A, Machova"'
Autor:
Lenka Hovorkova, Lucie Winkowska, Justina Skorepova, Manuela Krumbholz, Adela Benesova, Vaclava Polivkova, Julia Alten, Michela Bardini, Claus Meyer, Rathana Kim, Toby N. Trahair, Emmanuelle Clappier, Sabina Chiaretti, Michelle Henderson, Rosemary Sutton, Lucie Sramkova, Jan Stary, Katerina Machova Polakova, Rolf Marschalek, Markus Metzler, Giovanni Cazzaniga, Gunnar Cario, Jan Trka, Marketa Zaliova, Jan Zuna
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-7 (2024)
Abstract Background The BCR::ABL1 is a hallmark of chronic myeloid leukemia (CML) and is also found in acute lymphoblastic leukemia (ALL). Most genomic breaks on the BCR side occur in two regions - Major and minor - leading to p210 and p190 fusion pr
Externí odkaz:
https://doaj.org/article/7d6bde3a548d4461bac54306fa7daa23
Autor:
Pavel Burda, Alzbeta Hlavackova, Vendula Polivkova, Nikola Curik, Adam Laznicka, Jitka Krizkova, Jiri Suttnar, Pavel Klener, Katerina Machova Polakova
Publikováno v:
Molecular Metabolism, Vol 88, Iss , Pp 102016- (2024)
Objective: A prominent, safe and efficient therapy for patients with chronic myeloid leukemia (CML) is inhibiting oncogenic protein BCR::ABL1 in a targeted manner with imatinib, a tyrosine kinase inhibitor. A substantial part of patients treated with
Externí odkaz:
https://doaj.org/article/5291343c15e94e9fb1424c43740d28fb
Autor:
Petra Belohlavkova, Daniela Zackova, Hana Klamova, Edgar Faber, Michal Karas, Lukas Stejskal, Eduard Cmunt, Olga Cerna, Ivana Jeziskova, Katerina Machova Polakova, Pavel Zak, Tereza Jurkova, Marika Chrapava, Jiri Mayer
Publikováno v:
Cancer Medicine, Vol 13, Iss 17, Pp n/a-n/a (2024)
Abstract Background To evaluate the outcomes of first‐line imatinib versus nilotinib treatment for chronic myeloid leukemia in the chronic phase (CML‐CP) in real‐world clinical practice. Methods A propensity score analysis was performed to elim
Externí odkaz:
https://doaj.org/article/a3f1e095df1743329fc066dd5daac827
Publikováno v:
Marketing i Menedžment Innovacij, Vol 15, Iss 1, Pp 1-14 (2024)
The innovation process is a key factor in developing and maintaining competitiveness; therefore, the SME sector should focus on innovation as well. Examining the impact of corporate cooperation on innovation activity is a crucial element. The main go
Externí odkaz:
https://doaj.org/article/6e42f4ca97ac42618ab4800bc2dd2613
Autor:
Burda, Pavel, Hlavackova, Alzbeta, Polivkova, Vendula, Curik, Nikola, Laznicka, Adam, Krizkova, Jitka, Suttnar, Jiri, Klener, Pavel, Polakova, Katerina Machova
Publikováno v:
In Molecular Metabolism October 2024 88
Generosity as a status signal: Higher-testosterone men exhibit greater altruism in the dictator game
Autor:
Novakova, Julie, Tureček, Petr, Machová, Kamila, Sýkorová, Kateřina, Zíka, Vojtěch, Flegr, Jaroslav
Publikováno v:
In Evolution and Human Behavior September 2024 45(5)
Autor:
Kateřina, Kohoutková, Kristýna, Machová, Radka, Procházková, Aneta, Makovcová, Štěpán, Zítek, Ivona, Svobodová
Publikováno v:
In Applied Animal Behaviour Science August 2024 277
Autor:
Dolnikova, Alexandra, Kazantsev, Dmitry, Klanova, Magdalena, Pokorna, Eva, Sovilj, Dana, Kelemen, Cristina Daniela, Tuskova, Liliana, Hoferkova, Eva, Mraz, Marek, Helman, Karel, Curik, Nikola, Machova Polakova, Katerina, Andera, Ladislav, Trneny, Marek, Klener, Pavel
Publikováno v:
In Blood Advances 9 July 2024 8(13):3532-3543
Publikováno v:
npj Science of Food, Vol 7, Iss 1, Pp 1-11 (2023)
Abstract EPA + DHA intake in land-locked central Europe (CE) is barely fulfilled. Imported marine fish/farmed salmonids are likely the backbone of an ailing EPA + DHA security. Supplementing with captured marine fish oil capsules (~0.5 g up to 1.6 g
Externí odkaz:
https://doaj.org/article/afac5c96a00444e5b3d86fc0a109181b
Autor:
Calta, Jan, Žáková, Eliška, Krupa, Emil, Čítek, Jaroslav, Dvořáková Machová, Karolína, Tichý, Ladislav, Stibal, Jan, Vostrý, Luboš
Publikováno v:
In Livestock Science May 2024 283